nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—lymphatic system cancer	0.504	0.827	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—lymphatic system cancer	0.105	0.173	CbGbCtD
Foscarnet—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.0008	0.00205	CcSEcCtD
Foscarnet—Feeling abnormal—Teniposide—lymphatic system cancer	0.000799	0.00204	CcSEcCtD
Foscarnet—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000793	0.00203	CcSEcCtD
Foscarnet—Chills—Bleomycin—lymphatic system cancer	0.000789	0.00202	CcSEcCtD
Foscarnet—Skin discolouration—Methotrexate—lymphatic system cancer	0.000784	0.002	CcSEcCtD
Foscarnet—Renal failure—Mitoxantrone—lymphatic system cancer	0.000781	0.002	CcSEcCtD
Foscarnet—Nausea—Mechlorethamine—lymphatic system cancer	0.000781	0.002	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000776	0.00199	CcSEcCtD
Foscarnet—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.000773	0.00198	CcSEcCtD
Foscarnet—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000773	0.00198	CcSEcCtD
Foscarnet—Abdominal pain—Teniposide—lymphatic system cancer	0.000766	0.00196	CcSEcCtD
Foscarnet—Body temperature increased—Teniposide—lymphatic system cancer	0.000766	0.00196	CcSEcCtD
Foscarnet—Paraesthesia—Fludarabine—lymphatic system cancer	0.000765	0.00196	CcSEcCtD
Foscarnet—Hallucination—Carmustine—lymphatic system cancer	0.000764	0.00195	CcSEcCtD
Foscarnet—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000764	0.00195	CcSEcCtD
Foscarnet—Dyspnoea—Fludarabine—lymphatic system cancer	0.00076	0.00194	CcSEcCtD
Foscarnet—Haematuria—Mitoxantrone—lymphatic system cancer	0.000758	0.00194	CcSEcCtD
Foscarnet—Dyspepsia—Fludarabine—lymphatic system cancer	0.00075	0.00192	CcSEcCtD
Foscarnet—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000746	0.00191	CcSEcCtD
Foscarnet—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000742	0.0019	CcSEcCtD
Foscarnet—Decreased appetite—Fludarabine—lymphatic system cancer	0.000741	0.00189	CcSEcCtD
Foscarnet—Fatigue—Fludarabine—lymphatic system cancer	0.000735	0.00188	CcSEcCtD
Foscarnet—Hallucination—Vincristine—lymphatic system cancer	0.000729	0.00186	CcSEcCtD
Foscarnet—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000729	0.00186	CcSEcCtD
Foscarnet—Pain—Fludarabine—lymphatic system cancer	0.000729	0.00186	CcSEcCtD
Foscarnet—Constipation—Fludarabine—lymphatic system cancer	0.000729	0.00186	CcSEcCtD
Foscarnet—Respiratory failure—Methotrexate—lymphatic system cancer	0.000721	0.00184	CcSEcCtD
Foscarnet—Urethral disorder—Vincristine—lymphatic system cancer	0.000718	0.00184	CcSEcCtD
Foscarnet—Eye disorder—Carmustine—lymphatic system cancer	0.000717	0.00183	CcSEcCtD
Foscarnet—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000715	0.00183	CcSEcCtD
Foscarnet—Flushing—Carmustine—lymphatic system cancer	0.000712	0.00182	CcSEcCtD
Foscarnet—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00071	0.00182	CcSEcCtD
Foscarnet—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000708	0.00181	CcSEcCtD
Foscarnet—Anaemia—Bleomycin—lymphatic system cancer	0.000708	0.00181	CcSEcCtD
Foscarnet—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000702	0.0018	CcSEcCtD
Foscarnet—Asthenia—Teniposide—lymphatic system cancer	0.000696	0.00178	CcSEcCtD
Foscarnet—Melaena—Methotrexate—lymphatic system cancer	0.000692	0.00177	CcSEcCtD
Foscarnet—Malaise—Bleomycin—lymphatic system cancer	0.00069	0.00177	CcSEcCtD
Foscarnet—Pruritus—Teniposide—lymphatic system cancer	0.000686	0.00175	CcSEcCtD
Foscarnet—Leukopenia—Bleomycin—lymphatic system cancer	0.000685	0.00175	CcSEcCtD
Foscarnet—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.000684	0.00175	CcSEcCtD
Foscarnet—Body temperature increased—Fludarabine—lymphatic system cancer	0.000674	0.00172	CcSEcCtD
Foscarnet—Cough—Bleomycin—lymphatic system cancer	0.000668	0.00171	CcSEcCtD
Foscarnet—Diarrhoea—Teniposide—lymphatic system cancer	0.000663	0.0017	CcSEcCtD
Foscarnet—Chest pain—Bleomycin—lymphatic system cancer	0.000652	0.00167	CcSEcCtD
Foscarnet—Myalgia—Bleomycin—lymphatic system cancer	0.000652	0.00167	CcSEcCtD
Foscarnet—Coma—Methotrexate—lymphatic system cancer	0.000647	0.00165	CcSEcCtD
Foscarnet—Back pain—Carmustine—lymphatic system cancer	0.000646	0.00165	CcSEcCtD
Foscarnet—Discomfort—Bleomycin—lymphatic system cancer	0.000644	0.00165	CcSEcCtD
Foscarnet—Chills—Mitoxantrone—lymphatic system cancer	0.00064	0.00164	CcSEcCtD
Foscarnet—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00064	0.00164	CcSEcCtD
Foscarnet—Urine output increased—Methotrexate—lymphatic system cancer	0.00064	0.00164	CcSEcCtD
Foscarnet—Neoplasm—Methotrexate—lymphatic system cancer	0.00064	0.00164	CcSEcCtD
Foscarnet—Confusional state—Bleomycin—lymphatic system cancer	0.00063	0.00161	CcSEcCtD
Foscarnet—Tremor—Carmustine—lymphatic system cancer	0.000626	0.0016	CcSEcCtD
Foscarnet—Oedema—Bleomycin—lymphatic system cancer	0.000625	0.0016	CcSEcCtD
Foscarnet—Infection—Bleomycin—lymphatic system cancer	0.000621	0.00159	CcSEcCtD
Foscarnet—Anaemia—Carmustine—lymphatic system cancer	0.000618	0.00158	CcSEcCtD
Foscarnet—Back pain—Vincristine—lymphatic system cancer	0.000617	0.00158	CcSEcCtD
Foscarnet—Vomiting—Teniposide—lymphatic system cancer	0.000616	0.00158	CcSEcCtD
Foscarnet—Sepsis—Methotrexate—lymphatic system cancer	0.000614	0.00157	CcSEcCtD
Foscarnet—Agitation—Carmustine—lymphatic system cancer	0.000614	0.00157	CcSEcCtD
Foscarnet—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000612	0.00156	CcSEcCtD
Foscarnet—Asthenia—Fludarabine—lymphatic system cancer	0.000611	0.00156	CcSEcCtD
Foscarnet—Rash—Teniposide—lymphatic system cancer	0.000611	0.00156	CcSEcCtD
Foscarnet—Dermatitis—Teniposide—lymphatic system cancer	0.000611	0.00156	CcSEcCtD
Foscarnet—Headache—Teniposide—lymphatic system cancer	0.000607	0.00155	CcSEcCtD
Foscarnet—Pruritus—Fludarabine—lymphatic system cancer	0.000603	0.00154	CcSEcCtD
Foscarnet—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000602	0.00154	CcSEcCtD
Foscarnet—Back pain—Mitoxantrone—lymphatic system cancer	0.000601	0.00154	CcSEcCtD
Foscarnet—Leukopenia—Carmustine—lymphatic system cancer	0.000598	0.00153	CcSEcCtD
Foscarnet—Anorexia—Bleomycin—lymphatic system cancer	0.000596	0.00152	CcSEcCtD
Foscarnet—Anaemia—Vincristine—lymphatic system cancer	0.00059	0.00151	CcSEcCtD
Foscarnet—Agitation—Vincristine—lymphatic system cancer	0.000586	0.0015	CcSEcCtD
Foscarnet—Polyuria—Methotrexate—lymphatic system cancer	0.000585	0.0015	CcSEcCtD
Foscarnet—Hypotension—Bleomycin—lymphatic system cancer	0.000584	0.00149	CcSEcCtD
Foscarnet—Diarrhoea—Fludarabine—lymphatic system cancer	0.000583	0.00149	CcSEcCtD
Foscarnet—Convulsion—Carmustine—lymphatic system cancer	0.000579	0.00148	CcSEcCtD
Foscarnet—Hypertension—Carmustine—lymphatic system cancer	0.000577	0.00148	CcSEcCtD
Foscarnet—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000576	0.00147	CcSEcCtD
Foscarnet—Nausea—Teniposide—lymphatic system cancer	0.000576	0.00147	CcSEcCtD
Foscarnet—Anaemia—Mitoxantrone—lymphatic system cancer	0.000574	0.00147	CcSEcCtD
Foscarnet—Leukopenia—Vincristine—lymphatic system cancer	0.000571	0.00146	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000569	0.00146	CcSEcCtD
Foscarnet—Chest pain—Carmustine—lymphatic system cancer	0.000569	0.00145	CcSEcCtD
Foscarnet—Myalgia—Carmustine—lymphatic system cancer	0.000569	0.00145	CcSEcCtD
Foscarnet—Anxiety—Carmustine—lymphatic system cancer	0.000567	0.00145	CcSEcCtD
Foscarnet—Paraesthesia—Bleomycin—lymphatic system cancer	0.000561	0.00143	CcSEcCtD
Foscarnet—Malaise—Mitoxantrone—lymphatic system cancer	0.00056	0.00143	CcSEcCtD
Foscarnet—Dyspnoea—Bleomycin—lymphatic system cancer	0.000557	0.00142	CcSEcCtD
Foscarnet—Renal failure acute—Methotrexate—lymphatic system cancer	0.000557	0.00142	CcSEcCtD
Foscarnet—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000556	0.00142	CcSEcCtD
Foscarnet—Convulsion—Vincristine—lymphatic system cancer	0.000553	0.00141	CcSEcCtD
Foscarnet—Hypertension—Vincristine—lymphatic system cancer	0.000551	0.00141	CcSEcCtD
Foscarnet—Confusional state—Carmustine—lymphatic system cancer	0.00055	0.00141	CcSEcCtD
Foscarnet—Oedema—Carmustine—lymphatic system cancer	0.000545	0.00139	CcSEcCtD
Foscarnet—Decreased appetite—Bleomycin—lymphatic system cancer	0.000543	0.00139	CcSEcCtD
Foscarnet—Myalgia—Vincristine—lymphatic system cancer	0.000543	0.00139	CcSEcCtD
Foscarnet—Cough—Mitoxantrone—lymphatic system cancer	0.000542	0.00139	CcSEcCtD
Foscarnet—Infection—Carmustine—lymphatic system cancer	0.000542	0.00139	CcSEcCtD
Foscarnet—Vomiting—Fludarabine—lymphatic system cancer	0.000542	0.00139	CcSEcCtD
Foscarnet—Convulsion—Mitoxantrone—lymphatic system cancer	0.000538	0.00138	CcSEcCtD
Foscarnet—Rash—Fludarabine—lymphatic system cancer	0.000537	0.00137	CcSEcCtD
Foscarnet—Dermatitis—Fludarabine—lymphatic system cancer	0.000537	0.00137	CcSEcCtD
Foscarnet—Hypertension—Mitoxantrone—lymphatic system cancer	0.000536	0.00137	CcSEcCtD
Foscarnet—Pain—Bleomycin—lymphatic system cancer	0.000534	0.00137	CcSEcCtD
Foscarnet—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000534	0.00137	CcSEcCtD
Foscarnet—Headache—Fludarabine—lymphatic system cancer	0.000534	0.00136	CcSEcCtD
Foscarnet—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000529	0.00135	CcSEcCtD
Foscarnet—Chest pain—Mitoxantrone—lymphatic system cancer	0.000529	0.00135	CcSEcCtD
Foscarnet—Myalgia—Mitoxantrone—lymphatic system cancer	0.000529	0.00135	CcSEcCtD
Foscarnet—Anxiety—Mitoxantrone—lymphatic system cancer	0.000527	0.00135	CcSEcCtD
Foscarnet—Discomfort—Mitoxantrone—lymphatic system cancer	0.000523	0.00134	CcSEcCtD
Foscarnet—Oedema—Vincristine—lymphatic system cancer	0.000521	0.00133	CcSEcCtD
Foscarnet—Anorexia—Carmustine—lymphatic system cancer	0.00052	0.00133	CcSEcCtD
Foscarnet—Infection—Vincristine—lymphatic system cancer	0.000517	0.00132	CcSEcCtD
Foscarnet—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000515	0.00132	CcSEcCtD
Foscarnet—Confusional state—Mitoxantrone—lymphatic system cancer	0.000511	0.00131	CcSEcCtD
Foscarnet—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00051	0.0013	CcSEcCtD
Foscarnet—Hypotension—Carmustine—lymphatic system cancer	0.00051	0.0013	CcSEcCtD
Foscarnet—Oedema—Mitoxantrone—lymphatic system cancer	0.000507	0.0013	CcSEcCtD
Foscarnet—Nausea—Fludarabine—lymphatic system cancer	0.000506	0.00129	CcSEcCtD
Foscarnet—Infection—Mitoxantrone—lymphatic system cancer	0.000504	0.00129	CcSEcCtD
Foscarnet—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000503	0.00129	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000497	0.00127	CcSEcCtD
Foscarnet—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000496	0.00127	CcSEcCtD
Foscarnet—Anorexia—Vincristine—lymphatic system cancer	0.000496	0.00127	CcSEcCtD
Foscarnet—Body temperature increased—Bleomycin—lymphatic system cancer	0.000494	0.00126	CcSEcCtD
Foscarnet—Insomnia—Carmustine—lymphatic system cancer	0.000493	0.00126	CcSEcCtD
Foscarnet—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00049	0.00125	CcSEcCtD
Foscarnet—Paraesthesia—Carmustine—lymphatic system cancer	0.00049	0.00125	CcSEcCtD
Foscarnet—Hypotension—Vincristine—lymphatic system cancer	0.000486	0.00124	CcSEcCtD
Foscarnet—Dyspnoea—Carmustine—lymphatic system cancer	0.000486	0.00124	CcSEcCtD
Foscarnet—Somnolence—Carmustine—lymphatic system cancer	0.000485	0.00124	CcSEcCtD
Foscarnet—Anorexia—Mitoxantrone—lymphatic system cancer	0.000483	0.00124	CcSEcCtD
Foscarnet—Ataxia—Methotrexate—lymphatic system cancer	0.000483	0.00124	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000474	0.00121	CcSEcCtD
Foscarnet—Decreased appetite—Carmustine—lymphatic system cancer	0.000474	0.00121	CcSEcCtD
Foscarnet—Hypotension—Mitoxantrone—lymphatic system cancer	0.000474	0.00121	CcSEcCtD
Foscarnet—Insomnia—Vincristine—lymphatic system cancer	0.000471	0.0012	CcSEcCtD
Foscarnet—Paraesthesia—Vincristine—lymphatic system cancer	0.000467	0.0012	CcSEcCtD
Foscarnet—Pain—Carmustine—lymphatic system cancer	0.000466	0.00119	CcSEcCtD
Foscarnet—Constipation—Carmustine—lymphatic system cancer	0.000466	0.00119	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000463	0.00118	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000462	0.00118	CcSEcCtD
Foscarnet—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000455	0.00116	CcSEcCtD
Foscarnet—Decreased appetite—Vincristine—lymphatic system cancer	0.000453	0.00116	CcSEcCtD
Foscarnet—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000452	0.00116	CcSEcCtD
Foscarnet—Somnolence—Mitoxantrone—lymphatic system cancer	0.000451	0.00115	CcSEcCtD
Foscarnet—Feeling abnormal—Carmustine—lymphatic system cancer	0.000449	0.00115	CcSEcCtD
Foscarnet—Fatigue—Vincristine—lymphatic system cancer	0.000449	0.00115	CcSEcCtD
Foscarnet—Asthenia—Bleomycin—lymphatic system cancer	0.000448	0.00115	CcSEcCtD
Foscarnet—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000446	0.00114	CcSEcCtD
Foscarnet—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000446	0.00114	CcSEcCtD
Foscarnet—Constipation—Vincristine—lymphatic system cancer	0.000445	0.00114	CcSEcCtD
Foscarnet—Pain—Vincristine—lymphatic system cancer	0.000445	0.00114	CcSEcCtD
Foscarnet—Pruritus—Bleomycin—lymphatic system cancer	0.000442	0.00113	CcSEcCtD
Foscarnet—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000441	0.00113	CcSEcCtD
Foscarnet—Fatigue—Mitoxantrone—lymphatic system cancer	0.000437	0.00112	CcSEcCtD
Foscarnet—Pancreatitis—Methotrexate—lymphatic system cancer	0.000436	0.00111	CcSEcCtD
Foscarnet—Pain—Mitoxantrone—lymphatic system cancer	0.000434	0.00111	CcSEcCtD
Foscarnet—Constipation—Mitoxantrone—lymphatic system cancer	0.000434	0.00111	CcSEcCtD
Foscarnet—Body temperature increased—Carmustine—lymphatic system cancer	0.000431	0.0011	CcSEcCtD
Foscarnet—Abdominal pain—Carmustine—lymphatic system cancer	0.000431	0.0011	CcSEcCtD
Foscarnet—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000426	0.00109	CcSEcCtD
Foscarnet—Pancytopenia—Methotrexate—lymphatic system cancer	0.000422	0.00108	CcSEcCtD
Foscarnet—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000418	0.00107	CcSEcCtD
Foscarnet—Dysuria—Methotrexate—lymphatic system cancer	0.000415	0.00106	CcSEcCtD
Foscarnet—Neutropenia—Methotrexate—lymphatic system cancer	0.000415	0.00106	CcSEcCtD
Foscarnet—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000415	0.00106	CcSEcCtD
Foscarnet—Abdominal pain—Vincristine—lymphatic system cancer	0.000412	0.00105	CcSEcCtD
Foscarnet—Body temperature increased—Vincristine—lymphatic system cancer	0.000412	0.00105	CcSEcCtD
Foscarnet—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000401	0.00102	CcSEcCtD
Foscarnet—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000401	0.00102	CcSEcCtD
Foscarnet—Vomiting—Bleomycin—lymphatic system cancer	0.000397	0.00102	CcSEcCtD
Foscarnet—Rash—Bleomycin—lymphatic system cancer	0.000394	0.00101	CcSEcCtD
Foscarnet—Dermatitis—Bleomycin—lymphatic system cancer	0.000394	0.00101	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000393	0.001	CcSEcCtD
Foscarnet—Asthenia—Carmustine—lymphatic system cancer	0.000391	0.001	CcSEcCtD
Foscarnet—Renal failure—Methotrexate—lymphatic system cancer	0.000389	0.000995	CcSEcCtD
Foscarnet—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000385	0.000984	CcSEcCtD
Foscarnet—Haematuria—Methotrexate—lymphatic system cancer	0.000378	0.000966	CcSEcCtD
Foscarnet—Asthenia—Vincristine—lymphatic system cancer	0.000374	0.000955	CcSEcCtD
Foscarnet—Diarrhoea—Carmustine—lymphatic system cancer	0.000373	0.000954	CcSEcCtD
Foscarnet—Nausea—Bleomycin—lymphatic system cancer	0.000371	0.000949	CcSEcCtD
Foscarnet—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00037	0.000945	CcSEcCtD
Foscarnet—Asthenia—Mitoxantrone—lymphatic system cancer	0.000364	0.00093	CcSEcCtD
Foscarnet—Dizziness—Carmustine—lymphatic system cancer	0.000361	0.000922	CcSEcCtD
Foscarnet—Diarrhoea—Vincristine—lymphatic system cancer	0.000356	0.000911	CcSEcCtD
Foscarnet—Pharyngitis—Methotrexate—lymphatic system cancer	0.000353	0.000902	CcSEcCtD
Foscarnet—Urethral disorder—Methotrexate—lymphatic system cancer	0.000349	0.000891	CcSEcCtD
Foscarnet—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000347	0.000887	CcSEcCtD
Foscarnet—Vomiting—Carmustine—lymphatic system cancer	0.000347	0.000887	CcSEcCtD
Foscarnet—Dizziness—Vincristine—lymphatic system cancer	0.000344	0.00088	CcSEcCtD
Foscarnet—Rash—Carmustine—lymphatic system cancer	0.000344	0.000879	CcSEcCtD
Foscarnet—Dermatitis—Carmustine—lymphatic system cancer	0.000344	0.000878	CcSEcCtD
Foscarnet—Headache—Carmustine—lymphatic system cancer	0.000342	0.000874	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000336	0.00086	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—lymphatic system cancer	0.000332	0.00085	CcSEcCtD
Foscarnet—Vomiting—Vincristine—lymphatic system cancer	0.000331	0.000846	CcSEcCtD
Foscarnet—Rash—Vincristine—lymphatic system cancer	0.000328	0.000839	CcSEcCtD
Foscarnet—Dermatitis—Vincristine—lymphatic system cancer	0.000328	0.000839	CcSEcCtD
Foscarnet—Headache—Vincristine—lymphatic system cancer	0.000326	0.000834	CcSEcCtD
Foscarnet—Nausea—Carmustine—lymphatic system cancer	0.000324	0.000828	CcSEcCtD
Foscarnet—Vomiting—Mitoxantrone—lymphatic system cancer	0.000322	0.000824	CcSEcCtD
Foscarnet—Rash—Mitoxantrone—lymphatic system cancer	0.00032	0.000817	CcSEcCtD
Foscarnet—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000319	0.000817	CcSEcCtD
Foscarnet—Chills—Methotrexate—lymphatic system cancer	0.000319	0.000816	CcSEcCtD
Foscarnet—Headache—Mitoxantrone—lymphatic system cancer	0.000318	0.000812	CcSEcCtD
Foscarnet—Nausea—Vincristine—lymphatic system cancer	0.000309	0.000791	CcSEcCtD
Foscarnet—Nausea—Mitoxantrone—lymphatic system cancer	0.000301	0.00077	CcSEcCtD
Foscarnet—Back pain—Methotrexate—lymphatic system cancer	0.000299	0.000766	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000287	0.000734	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—lymphatic system cancer	0.000286	0.000731	CcSEcCtD
Foscarnet—Malaise—Methotrexate—lymphatic system cancer	0.000279	0.000714	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—lymphatic system cancer	0.000277	0.000708	CcSEcCtD
Foscarnet—Cough—Methotrexate—lymphatic system cancer	0.00027	0.000691	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—lymphatic system cancer	0.000268	0.000686	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—lymphatic system cancer	0.000264	0.000674	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—lymphatic system cancer	0.000264	0.000674	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—lymphatic system cancer	0.000264	0.000674	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—lymphatic system cancer	0.00026	0.000666	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—lymphatic system cancer	0.000255	0.000651	CcSEcCtD
Foscarnet—Infection—Methotrexate—lymphatic system cancer	0.000251	0.000642	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000247	0.000632	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000244	0.000624	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—lymphatic system cancer	0.000241	0.000616	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—lymphatic system cancer	0.000236	0.000604	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00023	0.000588	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—lymphatic system cancer	0.000228	0.000584	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—lymphatic system cancer	0.000227	0.00058	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—lymphatic system cancer	0.000225	0.000576	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—lymphatic system cancer	0.000225	0.000574	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—lymphatic system cancer	0.000222	0.000569	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—lymphatic system cancer	0.00022	0.000561	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—lymphatic system cancer	0.000218	0.000557	CcSEcCtD
Foscarnet—Pain—Methotrexate—lymphatic system cancer	0.000216	0.000552	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000208	0.000532	CcSEcCtD
Foscarnet—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000207	0.000528	CcSEcCtD
Foscarnet—Abdominal pain—Methotrexate—lymphatic system cancer	0.0002	0.000511	CcSEcCtD
Foscarnet—Body temperature increased—Methotrexate—lymphatic system cancer	0.0002	0.000511	CcSEcCtD
Foscarnet—Asthenia—Methotrexate—lymphatic system cancer	0.000181	0.000463	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—lymphatic system cancer	0.000179	0.000457	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—lymphatic system cancer	0.000173	0.000442	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—lymphatic system cancer	0.000167	0.000427	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—lymphatic system cancer	0.000161	0.000411	CcSEcCtD
Foscarnet—Rash—Methotrexate—lymphatic system cancer	0.000159	0.000407	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—lymphatic system cancer	0.000159	0.000407	CcSEcCtD
Foscarnet—Headache—Methotrexate—lymphatic system cancer	0.000158	0.000405	CcSEcCtD
Foscarnet—Nausea—Methotrexate—lymphatic system cancer	0.00015	0.000384	CcSEcCtD
